Efficacy and safety of ertugliflozin in patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS MET trial

被引：0

作者：

Charbonnel, B. ^{[1
]}

Pascu, R. ^{[2
]}

Frias, J. ^{[3
]}

Pall, D. ^{[4
]}

Saur, D. ^{[2
]}

Darekar, A. ^{[5
]}

Huyck, S. ^{[6
]}

Shi, H. ^{[7
]}

Lauring, B. ^{[6
]}

Terra, S. ^{[8
]}

Rosenstock, J. ^{[9
]}

机构：

[1] Univ Nantes, Nantes, France

[2] Pfizer, Paris, France

[3] Natl Res Inst, Los Angeles, CA USA

[4] Univ Debrecen, Debrecen, Hungary

[5] Pfizer, Tadworth, England

[6] Merck & Co Inc, Kenilworth, NJ USA

[7] Pfizer, New York, NY USA

[8] Pfizer, Andover, MA USA

[9] Dallas Diabet Res Ctr Med City, Dallas, TX USA

来源：

DIABETOLOGIA | 2017年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

878

引用

页码：S406 / S407

页数：2

共 50 条

[31] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
Rosenstock, J
Magner, J
Krol, A
Taylor, T
[J]. DIABETES, 1998, 47 : A351 - A351
[32] EFFICACY AND SAFETY OF ANAGLIPTIN COMPARED WITH SITAGLIPTIN AS AN ADD-ON FOR PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
Jin, S. -M.
Park, S. W.
Yoon, K. -H.
Lee, M. -K.
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S135 - S136
[33] Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET) (vol 20, pg 520, 2017)
Rosenstock, Julio
Frias, Juan
Pall, Denes
Charbonnel, Bernard
Pascu, Raluca
Saur, Didier
Darekar, Amanda
Huyck, Susan
Shi, Harry
Lauring, Brett
Terra, Steven G.
[J]. DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2708 - 2708
[34] Ertugliflozin effectively improves glycaemic control as monotherapy in patients with type 2 diabetes: the VERTIS MONO trial
Terra, S.
Davies, M. J.
Frias, J.
Derosa, G.
Darekar, A.
Focht, K.
Golm, G.
Johnson, J.
Saur, D.
Dagogo-Jack, S.
[J]. DIABETOLOGIA, 2016, 59 : S346 - S346
[35] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
Wilding, J. P. H.
Charpentier, G.
Hollander, P.
Gonzalez-Galvez, G.
Mathieu, C.
Vercruysse, F.
Usiskin, K.
Law, G.
Black, S.
Canovatchel, W.
Meininger, G.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1267 - 1282
[36] Efficacy and safety of saxagliptin and glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy: results from the SPECIFY study
Gu, T.
Zhu, L.
Niu, Q.
Li, C.
Bi, Y.
Zhu, D.
[J]. DIABETOLOGIA, 2018, 61 : S379 - S379
[37] Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy
Bailey, C. J.
Gross, J. L.
Yadav, M.
Iqbal, N.
Mansfield, T. A.
List, J. F.
[J]. DIABETOLOGIA, 2011, 54 : S67 - S67
[38] Efficacy and safety of alogliptin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise
Mekki, Q.
Fleck, P.
Wilson, C.
DeFronzo, R.
[J]. DIABETOLOGIA, 2008, 51 : S344 - S344
[39] Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial
Cai Xiao-Ling
Chen Ying-Li
Zhao Jia-Jun
Shan Zhong-Yan
Qiu Ming-Cai
Li Cheng-Jiang
Gu Wei
Tian Hao-Ming
Yang Hua-Zhang
Xue Yao-Ming
Yang Jin-Kui
Hong Tian-Pei
Ji Li-Nong
[J]. 中华医学杂志(英文版), 2015, 128 (10) : 1279 - 1287
[40] Safety and Efficacy of Ertugliflozin in Combination with Sitagliptin in Subjects with T2DM Inadequately Controlled on Diet and Exercise: The VERTIS SITA Trial
Lauring, Brett
Miller, Sam S.
Krumins, Tania
Zhou, Hao Jin
Huyck, Susan
Johnson, Jeremy
Golm, Gregory
Terra, Steven G.
Mancuso, James P.
Engel, Samuel S.
[J]. DIABETES, 2017, 66 : A319 - A320

← 1 2 3 4 5 →